Search

Your search keyword '"Vasudevaraja, Varshini"' showing total 211 results

Search Constraints

Start Over You searched for: Author "Vasudevaraja, Varshini" Remove constraint Author: "Vasudevaraja, Varshini"
211 results on '"Vasudevaraja, Varshini"'

Search Results

1. Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinoma

3. Molecular correlates of male germ cell tumors with overgrowth of components resembling somatic malignancies

4. Clinicopathologic and molecular spectrum of testicular sex cord-stromal tumors not amenable to specific histopathologic subclassification

8. TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition

10. Novel Androgen Receptor Splice Variant 7 in Gynecologic Tumors

15. Increased PI3K pathway activity is associated with recurrent breast cancer in patients with low and intermediate 21-gene recurrence score

16. YAP1-FAM118B Fusion Defines a Rare Subset of Childhood and Young Adulthood Meningiomas

18. Molecular and clinicopathologic features of gliomas harboring NTRK fusions

19. DNA Methylation Profiles Are Stable in H3 K27M-Mutant Diffuse Midline Glioma Neurosphere Cell Lines.

22. Functional and topographic effects on DNA methylation in IDH1/2 mutant cancers

24. The Prognostic Impact of Subclonal IDH1 Mutation in Grade 2-4 Astrocytomas

25. Supplementary Data from Innate αβ T Cells Mediate Antitumor Immunity by Orchestrating Immunogenic Macrophage Programming

26. Supp Table 1 from Innate αβ T Cells Mediate Antitumor Immunity by Orchestrating Immunogenic Macrophage Programming

27. Data from Innate αβ T Cells Mediate Antitumor Immunity by Orchestrating Immunogenic Macrophage Programming

28. Supplementary Data from Integrated Analysis of Ovarian Juvenile Granulosa Cell Tumors Reveals Distinct Epigenetic Signatures and Recurrent TERT Rearrangements

29. Supplementary Figure from DNA Methylation Profiling Identifies Subgroups of Lung Adenocarcinoma with Distinct Immune Cell Composition, DNA Methylation Age, and Clinical Outcome

30. Supplementary Figure from Integrated Analysis of Ovarian Juvenile Granulosa Cell Tumors Reveals Distinct Epigenetic Signatures and Recurrent TERT Rearrangements

31. Supplementary Figures S1, S2 from Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase–mutant Glioma

32. Supplementary Data from DNA Methylation Profiling Identifies Subgroups of Lung Adenocarcinoma with Distinct Immune Cell Composition, DNA Methylation Age, and Clinical Outcome

33. Data from Integrated Analysis of Ovarian Juvenile Granulosa Cell Tumors Reveals Distinct Epigenetic Signatures and Recurrent TERT Rearrangements

34. Supplementary Tables S1-S4 from Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase–mutant Glioma

36. Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors—A prospective study and guidelines for clinical testing

37. Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinoma

38. Clinical, Pathological, and Molecular Characteristics of Diffuse Spinal Cord Gliomas

39. DNA Methylation Profiling Identifies Subgroups of Lung Adenocarcinoma with Distinct Immune Cell Composition, DNA Methylation Age, and Clinical Outcome

40. Integrated Analysis of Ovarian Juvenile Granulosa Cell Tumors Reveals Distinct Epigenetic Signatures and Recurrent TERT Rearrangements

41. Association of hyperglycemia and molecular subclass on survival in IDH-wildtype glioblastoma

42. NCOG-11. ASSOCIATION OF HYPERGLYCEMIA AND TUMOR SUBCLASS ON SURVIVAL IN IDH-WILDTYPE GLIOBLASTOMA

43. RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer

45. IDH2 R172 Mutations Across Poorly Differentiated Sinonasal Tract Malignancies

46. Somatic Focal Copy Number Gains of Noncoding Regions of Receptor Tyrosine Kinase Genes in Treatment-Resistant Epilepsy

48. Abstract PR04: Epigenetic silencing of CDR1as drives IGF2BP3-mediated melanoma invasion and metastasis

49. Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapy

50. Author response: Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapy

Catalog

Books, media, physical & digital resources